← Leaderboards
John J Mariani
Columbia University Health Sciences
$4,401,660
Attributed
$4,401,660
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $775.2K · FY2006–21$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,401,660 · 5
By mechanism
R01$2,220,685 · 1
R21$1,296,670 · 3
K23$884,305 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Frances Rudnick Levin$39,078,718
- Edward V Nunes$88,947,598
- Richard W Foltin$21,307,956
- Marian W Fischman$5,515,675
- Sarah H Lisanby$7,610,671
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyPlacebosParticipantPharmacotherapyOutpatientsPharmaceutical PreparationsAnxietyCravingRandomizedPrimary OutcomePublic Health Medicine (Field)AbstinenceSymptomsTimelineWithdrawal SymptomDouble-Blind MethodGabapentinOutcome MeasurePilot ProjectsSleeplessnessEconomic CostResearch Project GrantsHealth Care CostsAlcohol Consumption
Grant awards (15)
Pregabalin Treatment of Alcohol Use Disorder.$192,375
R21 · FY2021 · AA · contact PI
Pregabalin Treatment of Alcohol Use Disorder.$232,875
R21 · FY2020 · AA · contact PI
Quetiapine Pharmacotherapy for Cannabis Dependence$549,423
R01 · FY2015 · DA · contact PI
Quetiapine Pharmacotherapy for Cannabis Dependence$557,791
R01 · FY2014 · DA · contact PI
Gabapentin Treatment of Benzodiazepine Dependence$199,750
R21 · FY2014 · DA · contact PI
Quetiapine Pharmacotherapy for Cannabis Dependence$535,479
R01 · FY2013 · DA · contact PI
Gabapentin Treatment of Benzodiazepine Dependence$239,700
R21 · FY2013 · DA · contact PI
Quetiapine Pharmacotherapy for Cannabis Dependence$577,992
R01 · FY2012 · DA · contact PI
Gabapentin for Abstinence Initiation in Alcohol Dependence$192,120
R21 · FY2011 · AA · contact PI
Gabapentin for Abstinence Initiation in Alcohol Dependence$239,850
R21 · FY2010 · AA · contact PI
Anticonvulsant Pharmacotherapy for Sedative-Hypnotic Use Disorders$176,861
K23 · FY2010 · DA · contact PI
Anticonvulsant Pharmacotherapy for Sedative-Hypnotic Use Disorders$176,861
K23 · FY2009 · DA · contact PI
Anticonvulsant Pharmacotherapy for Sedative-Hypnotic Use Disorders$176,861
K23 · FY2008 · DA · contact PI
Anticonvulsant Pharmacotherapy for Sedative-Hypnotic Use Disorders$176,861
K23 · FY2007 · DA · contact PI
Anticonvulsant Pharmacotherapy for Sedative-Hypnotic Use Disorders$176,861
K23 · FY2006 · DA · contact PI